These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10217554)

  • 1. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users.
    Krol A; Flynn C; Vlahov D; Miedema F; Coutinho RA; van Ameijden EJ
    Drug Alcohol Depend; 1999 Apr; 54(2):145-54. PubMed ID: 10217554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
    Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D
    AIDS; 1997 Aug; 11(10):1255-62. PubMed ID: 9256944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.
    Crum RM; Galai N; Cohn S; Celentano DD; Vlahov D
    Alcohol Clin Exp Res; 1996 Apr; 20(2):364-71. PubMed ID: 8730231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison.
    van Ameijden EJ; Krol A; Vlahov D; Flynn C; van Haastrecht HJ; Coutinho RA
    Subst Use Misuse; 1999 May; 34(6):845-65. PubMed ID: 10227114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.
    Kivelä PS; Krol A; Salminen MO; Geskus RB; Suni JI; Anttila VJ; Liitsola K; Zetterberg V; Miedema F; Berkhout B; Coutinho RA; Ristola MA
    Scand J Infect Dis; 2005; 37(4):276-83. PubMed ID: 15871166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young and recent-onset injecting drug users are at higher risk for HIV.
    Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
    Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Arch Intern Med; 2001 May; 161(10):1281-8. PubMed ID: 11371255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.
    Galai N; Vlahov D; Margolick JB; Chen K; Graham NM; Muñoz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):66-74. PubMed ID: 8548349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
    Galai N; Margolick JB; Astemborski J; Vlahov D
    Clin Immunol Immunopathol; 1996 May; 79(2):134-41. PubMed ID: 8620619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the force of infection for HCV in injecting drug users using interval-censored data.
    Castro-Sánchez A; Shkedy Z; Hens N; Aerts M; Geskus R; Prins M; Wiessing L; Kretzschmar M
    Epidemiol Infect; 2012 Jun; 140(6):1064-74. PubMed ID: 21910930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
    Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
    Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users.
    Piepenbrink MS; Samuel M; Zheng B; Carter B; Fucile C; Bunce C; Kiebala M; Khan AA; Thakar J; Maggirwar SB; Morse D; Rosenberg AF; Haughey NJ; Valenti W; Keefer MC; Kobie JJ
    PLoS One; 2016; 11(7):e0158641. PubMed ID: 27379802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
    Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.